Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study

Journal of the National Cancer Institute

Volumn 89, Issue 13, 1997, Pages 955-959

  Cooney, Kathleen A ^a,b,d   McCarthy, Jenifer D ^a   Lange, Ethan ^a   Huang, Li ^a   Miesfeldt, Susan ^c   Montie, James E ^a   Oesterling, Joseph E ^a   Sandler, Howard M ^a   Lange, Kenneth ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d Health Sciences Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER SUSCEPTIBILITY; CHROMOSOME 1Q; FAMILY STUDY; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER;

EID: 0030966230     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.13.955     Document Type: Article

References (23)

1. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A 1992; 89:3367-71.
2. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993;150:797-802.
3. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
4. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ, Epstein JI. Pathological features of hereditary prostate cancer. J Urol 1995;153:987-92.
5. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371-4.
6. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and non-parametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996;58:1347-63.
7. Narod SA, Dupont A, Cusan L, Diamond A, Gomez JL, Suburu R, et al. The impact of family history on early detection of prostate cancer. Nat Med 1995;1:99-101.
8. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, et al. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995;1:827-9.
9. Nichols WC, Koller DL, Slovis B, Forowd T, Terry VH, Arnold ND, et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 1997;15:277-80.
10. Matise TC, Perlin M, Chakravarti A. Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map [published erratum appears in Nat Genet 1994;7:215]. Nat Genet 1994;6:384-90.
11. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM, White R. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 1990;6:575-7.
12. Lange K, Weeks D, Boehnke M. Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE [letter]. Genet Epidemiol 1988;5:471-2
13. Overbeck LD, Weston MD, Kimberling WJ, Johnson DH. A new highly polymorphic dinucleotide (CT)n repeat polymorphism D1S158 on chromosome 1q isolated by microdissection. Hum Mol Genet 1992;1: 141.
14. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12:333-7.
15. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families [published erratum appears in Nat Genet 1996;13:16-7]. Nat Genet 1996;13:120-2.
16. Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E, et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci U S A 1995;92:5950-4.
17. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2 [published erratum appears in Nature 1996:379:749]. Nature 1995;378:789-92.
18. Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995;87:991-6.
19. Morton RA. Racial differences in adenocarcinoma of the prostate in North American men. Urology 1994;44:637-45.
20. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995;141:732-40.
21. Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG, et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 1995;60:361-4.
22. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996;58:1323-37.
23. Dib C, Faure S, Fizames C, Samson D, Drowot N, Vignal A, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152-4.